615 related articles for article (PubMed ID: 10769189)
21. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties.
Hu H; Marban E
Mol Pharmacol; 1998 May; 53(5):902-7. PubMed ID: 9584217
[TBL] [Abstract][Full Text] [Related]
22. Mapping of dihydropyridine binding residues in a less sensitive invertebrate L-type calcium channel (LCa v 1).
Senatore A; Boone A; Lam S; Dawson TF; Zhorov B; Spafford JD
Channels (Austin); 2011; 5(2):173-87. PubMed ID: 21487241
[TBL] [Abstract][Full Text] [Related]
23. Structural elements in domain IV that influence biophysical and pharmacological properties of human alpha1A-containing high-voltage-activated calcium channels.
Hans M; Urrutia A; Deal C; Brust PF; Stauderman K; Ellis SB; Harpold MM; Johnson EC; Williams ME
Biophys J; 1999 Mar; 76(3):1384-400. PubMed ID: 10049321
[TBL] [Abstract][Full Text] [Related]
24. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
Grabner M; Wang Z; Hering S; Striessnig J; Glossmann H
Neuron; 1996 Jan; 16(1):207-18. PubMed ID: 8562085
[TBL] [Abstract][Full Text] [Related]
25. Direct interaction of the calcium sensor protein synaptotagmin I with a cytoplasmic domain of the alpha1A subunit of the P/Q-type calcium channel.
Charvin N; L'evêque C; Walker D; Berton F; Raymond C; Kataoka M; Shoji-Kasai Y; Takahashi M; De Waard M; Seagar MJ
EMBO J; 1997 Aug; 16(15):4591-6. PubMed ID: 9303303
[TBL] [Abstract][Full Text] [Related]
26. Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.
Ito H; Klugbauer N; Hofmann F
Mol Pharmacol; 1997 Oct; 52(4):735-40. PubMed ID: 9380037
[TBL] [Abstract][Full Text] [Related]
27. Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels.
Peterson BZ; Tanada TN; Catterall WA
J Biol Chem; 1996 Mar; 271(10):5293-6. PubMed ID: 8621376
[TBL] [Abstract][Full Text] [Related]
28. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
29. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
Kozlowski R; Ehrhard P; Fischli W; Osterrieder W; Holck M
J Pharmacol Exp Ther; 1986 Sep; 238(3):1084-91. PubMed ID: 2427686
[TBL] [Abstract][Full Text] [Related]
30. A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels.
Kwok TC; Hui K; Kostelecki W; Ricker N; Selman G; Feng ZP; Roy PJ
PLoS Genet; 2008 May; 4(5):e1000067. PubMed ID: 18464914
[TBL] [Abstract][Full Text] [Related]
31. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
Liu J; Bangalore R; Rutledge A; Triggle DJ
Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
[TBL] [Abstract][Full Text] [Related]
32. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
33. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
Seebohm G; Chen J; Strutz N; Culberson C; Lerche C; Sanguinetti MC
Mol Pharmacol; 2003 Jul; 64(1):70-7. PubMed ID: 12815162
[TBL] [Abstract][Full Text] [Related]
34. Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action.
Tang S; Yatani A; Bahinski A; Mori Y; Schwartz A
Neuron; 1993 Dec; 11(6):1013-21. PubMed ID: 8274273
[TBL] [Abstract][Full Text] [Related]
35. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit.
Mitterdorfer J; Sinnegger MJ; Grabner M; Striessnig J; Glossmann H
Biochemistry; 1995 Jul; 34(29):9350-5. PubMed ID: 7626604
[TBL] [Abstract][Full Text] [Related]
36. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits.
Wappl E; Mitterdorfer J; Glossmann H; Striessnig J
J Biol Chem; 2001 Apr; 276(16):12730-5. PubMed ID: 11278630
[TBL] [Abstract][Full Text] [Related]
38. Identical inhibitory modulation of A-type potassium currents by dihydropyridine calcium channel agonists and antagonists.
Mlinar B; Enyeart JJ
Mol Pharmacol; 1994 Oct; 46(4):743-9. PubMed ID: 7969054
[TBL] [Abstract][Full Text] [Related]
39. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.
Eller P; Berjukov S; Wanner S; Huber I; Hering S; Knaus HG; Toth G; Kimball SD; Striessnig J
Br J Pharmacol; 2000 Jun; 130(3):669-77. PubMed ID: 10821797
[TBL] [Abstract][Full Text] [Related]
40. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
